Influenza Vaccine 1557484A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Influenza Vaccine 1557484A, covering 2014-02-07 to 2014-02-07. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years [Phase 3]